Research ArticleCancer Biology

PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors

See allHide authors and affiliations

Science Translational Medicine  13 Oct 2010:
Vol. 2, Issue 53, pp. 53ra75
DOI: 10.1126/scitranslmed.3001538

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article